Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition.

World J Gastrointest Surg · 2022 · PMC9258238 · PMID 35979416

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

According to a large cohort study, compared with sorafenib monotherapy, TACE combined with sorafenib showed a trend towards significant risk reduction in patients ( n = 1136) with vascular invasion (HR: 0.78; 95%CI: 0.59-1.02)[ 63 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.